Search Results for: Roche
Trials & Approvals Biogen
Biogen Halts Aduhelm’s Second EU Marketing Application
2022-04-25
Deals Eye Development
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Asia-Pacific AI
Israeli and South Korean Companies Collaborate in Drug Innovation with Data Platform
2022-04-19
World Hemophilia Day 2022 – “Access for All: Partnership. Policy. Progress. Engaging your government, integrating inherited bleeding disorders into national policy”
2022-04-17
Regulatory Alzheimer's Drug
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
R&D Immunotherapy
Roche’s Phase III Trial of ES-SCLC Immunotherapy Fails to Extend Progression-Free Survival
2022-04-05
COVID-19 COVID-19 Treatment
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
China
HitGen Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
2022-03-17
China Cancer
China’s InxMed Raises $50 Million to Inhibit Cancer-Resisting FAKs
2022-03-07
Trials & Approvals Sanofi
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
R&D Bispecific Antibody
The Lancet Publishes Data on Roche’s Long-Lasting Bispecific Antibody for Vision Loss
2022-01-25
Special Breast Cancer
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Innovation Roche
With A New Medical Device and Accompanying Platform, Roche Advances its Digital Ecosystem
2022-01-14
Asia-Pacific Sanofi
Sanofi Licenses ABL Bio’s Bispecific Antibody for Parkinson’s Disease
2022-01-13
Feature JPM
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
1 … 5 6 7 8 9 … 20
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top